Trajan Group Holdings (ASX:TRJ) EBIT : A$1.8 Mil (TTM As of Dec. 2023)

View and export this data going back to 2021. Start your Free Trial

What is Trajan Group Holdings EBIT?

Trajan Group Holdings's earnings before interest and taxes (EBIT) for the six months ended in Dec. 2023 was A$-1.3 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Dec. 2023 was A$1.8 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Trajan Group Holdings's annualized ROC % for the quarter that ended in Dec. 2023 was -0.17%. Trajan Group Holdings's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2023 was -3.96%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Trajan Group Holdings's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 was 0.84%.

Trajan Group Holdings EBIT Historical Data

The historical data trend for Trajan Group Holdings's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Trajan Group Holdings EBIT Chart

Trajan Group Holdings Annual Data

Trend

Jun21

Jun22

Jun23

EBIT

2.08

2.91

8.80

Trajan Group Holdings Semi-Annual Data
	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
EBIT	Get a 7-Day Free Trial			0.15	2.76	5.70	3.09	-1.32

Competitive Comparison of Trajan Group Holdings's EBIT

For the Medical Instruments & Supplies subindustry, Trajan Group Holdings's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Trajan Group Holdings's EV-to-EBIT Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Trajan Group Holdings's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Trajan Group Holdings's EV-to-EBIT falls into.

Trajan Group Holdings EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was A$1.8 Mil.

Trajan Group Holdings (ASX:TRJ) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Trajan Group Holdings's annualized ROC % for the quarter that ended in Dec. 2023 is calculated as:

	ROC % (Q: Dec. 2023 )
=	NOPAT	/	Average Invested Capital
=	Operating Income * ( 1 - Tax Rate % )	/	( (Invested Capital (Q: Jun. 2023 )	+	Invested Capital (Q: Dec. 2023 ))	/ count )
=	-2.926 * ( 1 - 88.49% )	/	( (201.222	+	191.791)	/ 2 )
=	-0.3367826	/	196.5065
=	-0.17 %

where

	Invested Capital		(Q: Jun. 2023 )
=	Total Assets	-	Accounts Payable & Accrued Expense	-	Excess Cash
=	Total Assets	-	Accounts Payable & Accrued Expense	-	( Cash, Cash Equivalents, Marketable Securities	-	max(0, Total Current Liabilities	-	Total Current Assets	+	Cash, Cash Equivalents, Marketable Securities	))
=	229.041	-	16.781	-	( 11.038	-	max(0, 39.196	-	69.708	+	11.038	))
=	201.222

	Invested Capital		(Q: Dec. 2023 )
=	Total Assets	-	Accounts Payable & Accrued Expense	-	Excess Cash
=	Total Assets	-	Accounts Payable & Accrued Expense	-	( Cash, Cash Equivalents, Marketable Securities	-	max(0, Total Current Liabilities	-	Total Current Assets	+	Cash, Cash Equivalents, Marketable Securities	))
=	217.984	-	14.674	-	( 11.519	-	max(0, 40.345	-	64.038	+	11.519	))
=	191.791

Note: The Operating Income data used here is two times the semi-annual (Dec. 2023) data.

2. Joel Greenblatt's definition of Return on Capital:

Trajan Group Holdings's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2023 is calculated as:

	ROC (Joel Greenblatt) %		(Q: Dec. 2023 )
=	EBIT	/	Average of (Net fixed Assets	+	Net Working Capital)
=	EBIT	/	Average of (Property, Plant and Equipment	+	Net Working Capital)
			Q: Jun. 2023		Q: Dec. 2023
=	EBIT	/	( ( (Property, Plant and Equipment + Net Working Capital)	+	(Property, Plant and Equipment + Net Working Capital) )	/	count )
=	-2.63	/	( ( (36.918 + max(31.236, 0))	+	(35.861 + max(28.911, 0)) )	/	2 )
=	-2.63	/	( ( 68.154	+	64.772 )	/	2 )
=	-2.63	/	66.463
=	-3.96 %

where Working Capital is:

	Working Capital		(Q: Jun. 2023 )
=	(Accounts Receivable	+	Total Inventories	+	Other Current Assets)	-	(Accounts Payable & Accrued Expense	+	Defer. Rev.	+	Other Current Liabilities)
=	(23.521	+	31.934	+	3.215)	-	(16.781	+	1.457	+	9.196)
=	31.236

	Working Capital		(Q: Dec. 2023 )
=	(Accounts Receivable	+	Total Inventories	+	Other Current Assets)	-	(Accounts Payable & Accrued Expense	+	Defer. Rev.	+	Other Current Liabilities)
=	(19.628	+	27.831	+	5.06)	-	(14.674	+	0.203	+	8.731)
=	28.911

When net working capital is negative, 0 is used.

Note: The EBIT data used here is two times the semi-annual (Dec. 2023) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Trajan Group Holdings's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %	=	EBIT (TTM)	/	Enterprise Value (Q: Dec. 2023 )
	=	1.778	/	211.161
	=	0.84 %

Trajan Group Holdings EBIT Related Terms

Thank you for viewing the detailed overview of Trajan Group Holdings's EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

Trajan Group Holdings (ASX:TRJ) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Trajan Group Holdings Ltd (ASX:TRJ) » Definitions » EBIT

Comparable Companies

Traded in Other Exchanges

N/A

Address

7 Argent Place, Ringwood, VIC, AUS, 3134

Website

https://www.trajanscimed.com

Trajan Group Holdings Ltd operates in the analytical science industry. The group operates in two segments namely, Analytical Products which design, manufacture, distribute, and sale of Analytical components and consumables, and Life Science Solutions which design, manufacture, distribute, and sale of pathology, automation workflow solutions, microsampling devices, testing, and data analysis. The majority of its revenue is derived from developing and manufacturing a range of precision consumable components and solutions. It operates predominantly in Malaysia, Japan, Australia, New Zealand, the USA, Europe, the Middle East, India and African countries.

Trajan Group Holdings (ASX:TRJ) Headlines

No Headlines